Additive effect of the mutations in the β3-adrenoceptor gene and UCP3 gene promoter on body fat distribution and glycemic control after weight reduction in overweight subjects with CAD or metabolic syndrome

International Journal of Obesity

Volumn 28, Issue 3, 2004, Pages 434-441

  Kim, O Y ^a   Cho, E Y ^b   Park, H Y ^b   Jang, Y ^a,b   Lee, J H ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

3 adrenergic receptor; Abdominal fat; Coronary artery disease; Metabolic syndrome; Mutation; Obesity; UCP3

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; C PEPTIDE; FATTY ACID; GLUCOSE; INSULIN; LIPID; UNCOUPLING PROTEIN 3;

ABDOMEN; ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD PRESSURE; BODY FAT; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FATTY ACID BLOOD LEVEL; FEMALE; GENE MUTATION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; VISCERA; WEIGHT REDUCTION; WILD TYPE;

ADIPOSE TISSUE; BLOOD GLUCOSE; CARRIER PROTEINS; CORONARY DISEASE; DIET, REDUCING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; ION CHANNELS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MUTATION; OBESITY; PROMOTER REGIONS (GENETICS); RECEPTORS, ADRENERGIC, BETA-3; WEIGHT LOSS;

EID: 1542270110     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802562     Document Type: Article

References (28)

1. Lowell BB, Spiegelman BM. Towards a molecular understanding of adaptive thermogenesis. Nature 2000; 404: 652-660.
2. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW. Relation of nody cat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254-260.
3. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary if the third report of the national cholesterol education program (NECP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 284: 2486-2509.
4. Hagstrom-Toft E, Thorne A, Reynisdottir S, Moberg E, Rossner S, Bolinder J, Arner P. Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo. Diabetes 2001; 50: 1604-1611.
5. Kwon SJ, Jang Y, Kim OY, Lee SM, Lee JH, Chung NS, Lee HC, Huh KB. Influence of age and obesity on visceral fat, muscle mass and cardiovascular risk factors In healthy Korean men. Kor J Lipidol 1999; 9: 393-405.
6. Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635-643.
7. Rosenbaum M, Leibel RL, Hirsch J. Medical progress: obesity. NEJM 1997; 337: 390-407.
8. Bouchard C. Genetics of obesity: an update on molecular markers. Int J Obes Relat Metab Disord 1995; 19: S10-S13.
9. Leibel RL, Chua Jr SC, Chung WK. Animal models of genetic obesity. In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R (eds). Progress in obesity research: 7. John Libbey: London; 1996. 263-271.
10. Fumeron F, Druack-Brown I, Betoulle D, Cassard-Doulcier AM, Tuzet S, Bouillaud F, Melchior JC, Ricquier D, Apfelbaum M. Polymorphism of uncoupling protein (UCP) and β3 adrenergic receptor genes in obese people submitted to a low calorie diet. Int J Obes Relat Metab Disord 1996; 20: 1051-1054.
11. Strosberg AD, Pietri-Rouxel F. Function and regulation of the β3-adrenergic receptor. Trends Pharmacol Sci 1996; 17: 373-381.
12. Thomas GN, Tomlinson B, Chan JCN, Young RP, Critchley JAJH. The Trp64Arg polymorphism of the β3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int J Obes Relat Metab Disord 2000; 25: 545-551.
13. Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T. Meta-analysis if the assocation of Trp64Arg polymorphism β3-adrenergic receptor gene with body mass index. J Endocrinol Metab 1988; 83: 2411-2444.
14. Clement K, Vaisse C, Manning BSJ, Basdevant A, Guy-Grand B, Ruiz J, Silver KD, Shuldiner AR, Froguel P, Strosberg AD. Genetic variation in the beta-3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. New Engl J Med 1995; 333: 352-354.
15. Yoshida T, Sakane N, Unekawa T, Sakai M, Takahashi T, Kondo M. Mutation of β3-adrenergic receptor gene and response to treatment of obesity. Lancet 1995; 346: 1433-1434.
16. Tchernorf A, Starling RD, Walston JD, Shuldiner AR, Dvorak R, Silver K, Mattews DE, Poehlman ET. Obesity-related phenotypes and the β3- adrenoceptor gene variant in postmenopausal women. Diabetes 1999; 48: 1425-1428.
17. Ricquier D, Bouillaud F. The uncoupling protein homologues: UCP1, UCP2, UCP3 StUCP and AtUCP. Biochem J 2000; 345: 161-179.
18. Otabe S, Clement K, Dina C, Pelloux V, Guy-Grand B, Froguel P, Vasseur F. A genetic variation in the 5′ flanking region of the UCP3 gene is associated wth body mass index in humans in interaction with physical activity. Diabetologia 2000; 43: 245-249.
19. Cottel D, Dallongeville J, Marécaux N, Arveiler D, Ferrières J, Bingham A, Ducimetière P, Amouyel P. Coronary heart disease risk factor clustering among three French regions. The WHO NOMICA population study. Atherosclerosis 1997; 134: 155.
20. Boss O, Hagen T, Lowell BB. Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes 2000; 49: 143-156.
21. Soanes G, Vidal-Puig A, Grujic D, Filier JS, Lowell BB. The uncoupling protein 3 gene: genomic structure, chromosomal localization and genetic basis for short and long form transcripts. J Biol Chem 1997; 272: 25433-25436.
22. Feve B, Emorine LJ, Lasnier F, Blin N, Baude B, Nahmlas C, Strosberg AD, Pairault J. Atypical β3-adrenergic receptor in 3T3-F442A adipocytes: pharmacological and molecular relationship with the human β3-adrenergic receptor. J Biol Chem 1991; 266: 20329-20336.
23. Korean Nutrition Society. Recommended Dietary Allowances for Koreans, 7th revision, Korean Nutrition Society; 2000.
24. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the β3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. New Engl J Med 1995; 333: 348-351.
25. Emorine L, Blin N, Strosberg AD. The human beta3-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci 1996; 15: 3-7.
26. Lonnqvist F, Thorne A, Nilsell K, Hoffstedt J, Arner P. A pathogenetic role of visceral fat β3-adrenoreceptors in obesity. J Clin Invest 1995; 95: 1109-1116.
27. Umekawa T, Yoshida T, Sakane N, Kogure A. Trp64Arg mutation of β3-adrenoceptor gene deteriorates lipolysis induced by β3- adrenoceptor agonist in human omental adipocytes. Am Diab Assoc 1999; 48: 117.
28. Walston J, Silver K, Bogardus C, Knowler WC, Cell FS, Austin S, Manning B, Strosberg AD, Stern MP, Raben N, Sorkin JD, Roth J, Shuldiner AR. Time of onset of non-insulin-dependent diabetes mellitus and genetic cariation in the β3-adrenergic receptor gene. New Engl J Med 1995; 333: 343-347.